• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

genetic test

DNA pixel
MedTech

Genetic test results harder to handle under new abortion rules

Texas' law virtually bans all abortions after six weeks. But prenatal tests can't diagnose genetic conditions before 11 weeks.
Sara Reardon, Kaiser Health News Jun 27, 2022 9:07am
Messenger RNA

RNA sequencing enhances pediatric cancer diagnoses: study

Jan 28, 2022 2:13pm
Gloved merger acquisitions

Sema4 signals $623M bid for genetic testing provider GeneDx

Jan 18, 2022 9:51am
close-up of money

Mesa Labs bids $300M for genetic test maker Agena Bioscience

Sep 14, 2021 12:21pm
close-up of a microbiological pipette in the genetic laboratory

Genome Medical plots growth spurt with VC raise, acquisition

Aug 30, 2021 8:00am
blood test tube

NeoGenomics moves forward with $390M option to buy out Inivata

May 6, 2021 12:27pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings